BENGALURU (Reuters) – Biological E. Ltd said on Monday its COVID-19 vaccine received an emergency use approval in India for use in children aged 12 to 18 years.
(Reporting by Anuron Kumar Mitra in Bengaluru; Editing by Shounak Dasgupta)
Biological E. COVID shot gets India emergency approval for 12-18 age group
Feb 21, 2022 | 7:29 AM
